Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial-Reference-Cited by-同舟云学术

Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial

Published:2018-10-22 Issue:6 Volume:49 Page:1617-1628
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Newitt David C.¹,Zhang Zheng²³⁴,Gibbs Jessica E.¹,Partridge Savannah C.⁵,Chenevert Thomas L.⁶,Rosen Mark A.⁷,Bolan Patrick J.⁸,Marques Helga S.³⁴,Aliu Sheye¹,Li Wen¹,Cimino Lisa⁹,Joe Bonnie N.¹,Umphrey Heidi¹⁰,Ojeda‐Fournier Haydee¹¹,Dogan Basak¹²¹³,Oh Karen¹⁴,Abe Hiroyuki¹⁵,Drukteinis Jennifer¹⁶¹⁷,Esserman Laura J.¹⁸,Hylton Nola M.¹,

Affiliation:

1. Department of Radiology and Biomedical Imaging University of California San Francisco California USA

2. Department of Biostatistics Brown University Providence Rhode Island USA

3. Center for Statistical Sciences Brown University Providence Rhode Island USA

4. American College of Radiology Imaging Network (ACRIN) Philadelphia Pennsylvania USA

5. Department of Radiology University of Washington Seattle Washington USA

6. Department of Radiology University of Michigan Ann Arbor Michigan USA

7. Department of Radiology Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

8. Center for Magnetic Resonance Research University of Minnesota Minneapolis Minnesota USA

9. American College of Radiology & ECOG‐ACRIN Cancer Research Group Philadelphia Pennsylvania USA

10. Department of Radiology University of Alabama Birmingham Alabama USA

11. Department of Radiology University of California San Diego California USA

12. Department of Radiology University of Texas MD Anderson Cancer Center Houston Texas USA

13. Department of Diagnostic Radiology University of Texas Southwestern Medical Center Houston Texas USA

14. Department of Radiology Oregon Health & Science University Portland Oregon USA

15. Department of Radiology University of Chicago Chicago Illinois USA

16. H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA

17. Department of Women's Imaging St. Joseph's Women's Hospital Tampa Florida USA

18. Department of Surgery University of California San Francisco California USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.26539

Reference40 articles.

1. Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

2. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

3. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial

4. Multi-Site Clinical Evaluation of DW-MRI as a Treatment Response Metric for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

5. DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fat-signal suppression in breast diffusion-weighted imaging: the Good, the Bad, and the Ugly;European Radiology;2024-08-07

2. Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer;European Radiology;2024-07-05

3. Non-contrast Breast MR Imaging;Radiologic Clinics of North America;2024-07

4. Vendor-Specific Correction Software for Apparent Diffusion Coefficient Bias Due to Gradient Nonlinearity in Breast Diffusion-Weighted Imaging Using Ice-Water Phantom;Journal of Computer Assisted Tomography;2024-06-18

5. Radiomics-Guided Multimodal Self-Attention Network For Predicting Pathological Complete Response In Breast MRI;2024 IEEE International Symposium on Biomedical Imaging (ISBI);2024-05-27